Insider Filings
Forms 3, 4 & 5
Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Jan 02, 2025 |
Director
Trans History: 92
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 189 | $225.52 | 7,537 |
Jan 02, 2025 |
Director
Trans History: 92
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 76 | -- | 7,461 |
Jan 02, 2025 |
Director
Trans History: 99
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 90 | $225.52 | 13,180 |
Jan 02, 2025 |
Director
Trans History: 99
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 324 | -- | 12,855 |
Jan 02, 2025 |
Director
Trans History: 17
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 266 | $225.52 | 962 |
Dec 16, 2024 |
Vice President & Controller
Trans History: 30
|
Vice President & Controller | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,341 | -- | 5,341 |
Nov 15, 2024 |
Director
Trans History: 131
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 791 | $97.92 | 28,426 |
Nov 15, 2024 |
Director
Trans History: 131
|
Director | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 504 | $229.00 | 27,922 |
Nov 15, 2024 |
Director
Trans History: 131
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 791 | -- | -- |
Nov 13, 2024 |
President & CEO, BA
Trans History: 39
|
President & CEO, BA | Form 4 | Other acquisition or disposition | -- | -- | 210 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.